Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia

American Journal of Hematology

Volumn 91, Issue 8, 2016, Pages 776-781

  Parry, Helen Marie ^a   Damery, Sarah ^a   Hudson, Christopher ^b   Maurer, Matthew J ^c   Cerhan, James R ^c   Pachnio, Annette ^a   Begum, Jusnara ^a   Slager, Susan L ^c   Fegan, Christopher ^d   Man, Stephen ^d   Pepper, Christopher ^d   Shanafelt, Tait D ^c   Pratt, Guy ^a   Moss, Paul A H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c MAYO CLINIC   (United States)

^d Division of Cancer Genetics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ANTIBODY TITER; ARTICLE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEROTYPE; SURVIVAL TIME; TIME TO TREATMENT;

EID: 84978269097     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24403     Document Type: Article

References (39)

1. Slobedman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J Virol 1999;73:4806–4812.
2. Lopo S, Vinagre E, Palminha P, et al. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Euro Surveill 2011;16:pii.
3. Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: The national health and nutrition examination surveys, 1988-2004. Clin Infect Dis 2010;50:1439–1447.
4. Vyse AJ, Hesketh LM, Pebody RG. The burden of infection with cytomegalovirus in England and Wales: How many women are infected in pregnancy? Epidemiol Infect 2009;137:526–533.
5. Chidrawar S, Khan N, Wei W, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009;155:423–432.
6. Derhovanessian E, Maier AB, Hahnel K, et al. Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol 2011;92:2746–2756.
7. Olsson J, Wikby A, Johansson B, et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: The Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000;121:187–201.
8. Trzonkowski P, Mysliwska J, Szmit E, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination–an impact of immunosenescence. Vaccine 2003;21:3826–3836.
9. Weaver JD, Huang MH, Albert M, et al. Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology 2002;59:371–378.
10. Strandberg TE, Pitkala KH, Tilvis RS. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. Jama 2009;301:380–382.
11. Savva GM, Pachnio A, Kaul B, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell 2013;12:381–387.
12. Parry HM, Birtwistle J, Whitelegg A, et al. Poor functional antibody responses are present in nearly all patients with chronic lymphocytic leukaemia, irrespective of total IgG concentration, and are associated with increased risk of infection. Br J Haematol 2015;171:887–890.
13. Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood 2015;126:573–581.
14. Nunes CT, Wong R, Mason M, et al. Expansion of a CD8+PD-1+ replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression. Clin Cancer Res 2011;18:678–687.
15. Mackus WJM, Frakking FNJ, Grummels A, et al. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Blood 2003;102:1057–1063.
16. Pourgheysari B, Bruton R, Parry H, et al. The number of cytomegalovirus-specific CD4+ T cells is markedly expanded in patients with B-cell chronic lymphocytic leukemia and determines the total CD4+ T-cell repertoire. Blood 2010;116:2968–2974.
17. Katrinakis G, Kyriakou D, Alexandrakis M, et al. Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia. Eur J Haematol 1995;55:33–41.
18. Pachnio A, Begum J, Fox A, et al. Acyclovir therapy reduces the cd4+ t cell response against the immunodominant pp65 protein from cytomegalovirus in immune competent individuals. PLoS One 2015;10:e0125287.
19. Shanafelt TD, Drake MT, Maurer MJ, et al. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 2011;117:1492–1498.
20. Dewald GW, Brockman SR, Paternoster SF, et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: Correlation with significant biological features of B-cell chronic lymphocytic leukaemia. Br J Haematol 2003;121:287–295.
21. Jelinek DF, Tschumper RC, Geyer SM, et al. Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. Br J Haematol 2001;115:854–861.
22. Shanafelt TD, Geyer SM, Bone ND, et al. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: A prognostic parameter with therapeutic potential. Br J Haematol 2008;140:537–546.
23. Kilgour AH, Firth C, Harrison R, et al. Seropositivity for CMV and IL-6 levels are associated with grip strength and muscle size in the elderly. Immun Ageing 2013;10:33.
24. Dollard SC, Staras SAS, Amin MM, et al. National prevalence estimates for cytomegalovirus igm and igg avidity and association between high igm antibody titer and low igg avidity ▿. Clin Vaccine Immunol 2011;18:1895–1899.
25. Steininger C, Widhopf GF, Ghia EM, et al. Recombinant antibodies encoded by IGHV1-69 react with pUL32, a phosphoprotein of cytomegalovirus and B-cell superantigen. Blood 2012;119:2293–2301.
26. Hecker M, Qiu D, Marquardt K, et al. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004;86:41–44.
27. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202–213.
28. Roberts ET, Haan MN, Dowd JB, et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010;172:363–371.
29. Hadrup SR, Strindhall J, Kollgaard T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006;176:2645–2653.
30. Wikby A, Nilsson B-O, Forsey R, et al. The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev 2006;127:695–704.
31. Trzonkowski P, Mysliwska J, Godlewska B, et al. Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain Behav Immun 2004;18:135–148.
32. Adami F, Guarini A, Pini M, et al. Serum levels of tumour necrosis factor-alpha in patients with B-cell chronic lymphocytic leukaemia. Eur J Cancer 1994;30A:1259–1263.
33. Callea V, Morabito F, Luise F, et al. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia. Haematologica 1996;81:310–315.
34. Ito S, Pophali P, Co W, et al. CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML. Bone Marrow Transplant 2013;48:1313–1316.
35. Elmaagacli AH, Steckel NK, Koldehoff M, et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: Evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 2011;118:1402–1412.
36. Wikby A, Johansson B, Olsson J, et al. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: The Swedish NONA immune study. Exp Gerontol 2002;37:445–453.
37. Vanura K, Rieder F, Kastner MT, et al. Chronic lymphocytic leukemia patients have a preserved cytomegalovirus-specific antibody response despite progressive hypogammaglobulinemia. PLoS One 2013;8:e78925.
38. te Raa GD, Pascutti MF, Garcia-Vallejo JJ, et al. CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia. Blood 2014;123:717–724.
39. Riches JC, Davies JK, McClanahan F, et al. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood 2013;121:1612–1621.